Cytomx analysts
WebAnalyst jobs 760,055 open jobs Coordinator jobs 540,291 open jobs Help Desk Technician jobs 5,545 open jobs Administrator jobs 476,673 open jobs ... WebDXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security …
Cytomx analysts
Did you know?
WebApr 10, 2024 · CytomX Therapeutics presently has a consensus target price of $3.17, indicating a potential upside of 103.30%. Stoke Therapeutics has a consensus target price of $24.57, indicating a potential ... WebCytomX Therapeutics, Inc. Analyst Report: AbbVie Inc AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. …
WebApr 13, 2024 · This is a summary of recent ratings and recommmendations for CytomX Therapeutics and Stoke Therapeutics, as provided by MarketBeat. CytomX Therapeutics currently has a consensus price target of $3.17, indicating a potential upside of 94.57%. Stoke Therapeutics has a consensus price target of $24.57, indicating a potential upside … WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX - Get Rating) has received an average rating of "Hold" from the twelve analysts that are covering the firm, Marketbeat reports.One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation and two have assigned a buy recommendation to the …
WebApr 13, 2024 · CytomX Therapeutics (CTMX) delivered earnings and revenue surprises of -9.38% and 9.20%, respectively, for the quarter ended September 2024. Do the numbers … WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has received an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeat …
WebCompany Type For Profit. Phone Number 6503510353. CytomX Therapeutics is a biotechnology company that focuses on developing proteolytically-activated antibodies. …
WebMar 31, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX– Get Rating) – Stock analysts at HC Wainwright raised their Q1 2024 earnings per share estimates for CytomX Therapeutics in a report released on... diamond backsplash stainlessWebApr 6, 2024 · CytomX Therapeutics is a smaller company with a market capitalization of US$181m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that... circle shaped housesWebWhat are analysts forecasts for CytomX stock? The 16 analysts offering price forecasts for CytomX have a median target of 6.42, with a high estimate of 16.00 and a low estimate … diamondbacks play baseball in which us stateWebCTMX Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for CytomX Therapeutics in the last 3 months. The average price target is $2.48 … diamond backsplash for kitchenWebApr 14, 2024 · CytomX Therapeutics, Inc. ( NASDAQ:CTMX – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are … circle shaped house on baptist church roadWebApr 5, 2024 · CytomX Therapeutics - CTMX News Today $1.80 -0.04 (-2.17%) (As of 03/21/2024 12:00 AM ET) Compare Today's Range $1.77 $1.87 50-Day Range $1.84 $2.86 52-Week Range $1.17 $3.12 Volume 946,693 shs Average Volume 2.86 million shs Market Capitalization $118.94 million P/E Ratio N/A Dividend Yield N/A Price Target $3.46 … circle shaped headWebThe CytomX Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, … diamondbacks play by play